Stokes Frank

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$7.22M

Insider Activity of Stokes Frank

According to the SEC Form 4 filings, Stokes Frank, being in a position of

  1. Chief Financial Officer at Castle Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10000 shares for $256,997,
    over all time since 2020-09-14, has bought 0 shares, and sold 144000 shares for $7.22M.

The largest sale of all time was on 2020-09-15 and amounted to 26000 shares of Castle Biosciences, Inc. for $1.28M.

Biography of Stokes Frank

No biography is available at this moment.

2024-08-07SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
10,000
0.0346%
$25.70$256,997+9.29%
2021-06-17SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
1,273
0.0049%
$73.00$92,929-41.52%
2021-06-16SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
2,127
0.0086%
$73.07$155,420-38.21%
2021-06-15SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
11,600
0.0465%
$73.02$847,032-38.44%
2021-01-12SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
7,500
0.0298%
$78.14$586,044-16.19%
2021-01-11SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
7,500
0.0307%
$78.06$585,427-13.46%
2020-11-13SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
13,000
0.0625%
$50.48$656,184+35.17%
2020-11-12SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
13,000
0.0618%
$51.26$666,363+31.05%
2020-10-14SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
13,000
0.0641%
$54.24$705,106+28.57%
2020-10-13SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
13,000
0.0623%
$54.79$712,283+23.74%
2020-09-15SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
26,000
0.132%
$49.06$1.28M+37.82%
2020-09-14SaleCastle Biosciences, Inc.
CSTL
Chief Financial Officer
26,000
0.0689%
$26.19$680,849+34.7%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.